BHVN ▲ +1.0% - Biohaven Ltd.
$BHVN - Biohaven Drives New Research in Graves' Disease: Phase 3 Pivotal Trial with BHV-1300 Underway and Three Scientific Posters at the 2026 American Thyroid Association Annual (ATA) Meeting
05-NOV-2026 07:31 AM ET
Share this post
More filings for $BHVN
BHVN ▲ +2.8% - Biohaven Ltd.Oct 29, 2026BHVN ▲ +6.0% - Biohaven Ltd.Oct 29, 2026BHVN ▼ -2.0% - Biohaven Ltd.Oct 26, 2026BHVN ▲ +1.5% - Biohaven Ltd.Oct 8, 2026BHVN ▼ -0.1% - Biohaven Ltd.Oct 8, 2026BHVN ▼ -0.7% - Biohaven Ltd.Sep 28, 2026
View full $BHVN filing history →💬 Comments
Loading comments…
Leave a comment
